Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case Report

The efficacy of sotorasib for patients with KRAS G12C-mutated lung cancer with poor performance status (PS) and active brain metastases remains unknown. Here, we present a case in which sotorasib was introduced as the third-line therapy for a patient whose PS worsened due to active multiple brain me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunimasa, Kei, Tamiya, Motohiro, Inoue, Takako, Kawamura, Takahisa, Nishino, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813774/
https://www.ncbi.nlm.nih.gov/pubmed/36619890
http://dx.doi.org/10.1016/j.jtocrr.2022.100442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813774/
https://www.ncbi.nlm.nih.gov/pubmed/36619890
http://dx.doi.org/10.1016/j.jtocrr.2022.100442

Ejemplares similares